CD8A and myeloid sarcoma: Although, MS is thought to be a CD4+ T-cell-mediated autoimmune disease, an increasing number of studies has reported a role of CD8+ T-cells in the initial relapse phase of MS since the frequency of CD8+ T-cells appearance in lesions was increased (Friese and Fugger, 2009; Salou et al., 2015).